Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Jul 1, 2022

Accession no.
0001209191-22-040108
Filed
Jul 1, 2022
Trade date
Jun 1-30, 2022
Filing delay
30 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $1.09K. It was filed 30 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 1, 2022Common StockPPurchaseAcquired+25$2.05+$51.2516,496Direct
Jun 2, 2022Common StockPPurchaseAcquired+25$2.08+$5216,521Direct
Jun 3, 2022Common StockPPurchaseAcquired+25$2.09+$52.2516,546Direct
Jun 6, 2022Common StockPPurchaseAcquired+27$2.07+$55.8916,573Direct
Jun 7, 2022Common StockPPurchaseAcquired+20$2.08+$41.616,593Direct
Jun 8, 2022Common StockPPurchaseAcquired+27$2.12+$57.2416,620Direct
Jun 9, 2022Common StockPPurchaseAcquired+27$2.09+$56.4316,647Direct
Jun 10, 2022Common StockPPurchaseAcquired+27$2.04+$55.0816,674Direct
Jun 13, 2022Common StockPPurchaseAcquired+27$2.01+$54.2716,701Direct
Jun 14, 2022Common StockPPurchaseAcquired+27$2.02+$54.5416,728Direct
Jun 15, 2022Common StockPPurchaseAcquired+27$1.98+$53.4615,755Direct
Jun 16, 2022Common StockPPurchaseAcquired+27$1.95+$52.6516,782Direct
Jun 17, 2022Common StockPPurchaseAcquired+27$1.94+$52.3816,809Direct
Jun 21, 2022Common StockPPurchaseAcquired+28$1.97+$55.1616,837Direct
Jun 22, 2022Common StockPPurchaseAcquired+25$1.99+$49.7516,862Direct
Jun 23, 2022Common StockPPurchaseAcquired+28$2.01+$56.2816,890Direct
Jun 24, 2022Common StockPPurchaseAcquired+28$2.11+$59.0816,918Direct
Jun 27, 2022Common StockPPurchaseAcquired+7$2.06+$14.4216,925Direct
Jun 28, 2022Common StockPPurchaseAcquired+23$2.06+$47.3816,948Direct
Jun 29, 2022Common StockPPurchaseAcquired+28$2.11+$59.0816,976Direct
Jun 30, 2022Common StockPPurchaseAcquired+28$2.08+$58.2417,004Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)